Application Information

This drug has been submitted to the FDA under the reference 021289/001.

Names and composition

"BRAVELLE" is the commercial name of a drug composed of UROFOLLITROPIN.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021289/001 BRAVELLE UROFOLLITROPIN INJECTABLE/INTRAMUSCULAR, SUBCUTANEOUS 75 IU per VIAL
021484/001 BRAVELLE UROFOLLITROPIN Injectable/ Subcutaneous 0.9%

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
019415/002 METRODIN UROFOLLITROPIN INJECTABLE/INTRAMUSCULAR 75 IU per AMP
019415/003 METRODIN UROFOLLITROPIN INJECTABLE/INTRAMUSCULAR 150 IU per AMP
019415/004 FERTINEX UROFOLLITROPIN INJECTABLE/SUBCUTANEOUS 150 IU per AMP
019415/005 FERTINEX UROFOLLITROPIN INJECTABLE/SUBCUTANEOUS 75 IU per AMP
021289/001 BRAVELLE UROFOLLITROPIN INJECTABLE/INTRAMUSCULAR, SUBCUTANEOUS 75 IU per VIAL
021484/001 BRAVELLE UROFOLLITROPIN Injectable/ Subcutaneous 0.9%

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved